Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Modest biotech rally ends bumpy week

    Biotech stocks recovered some of the week's losses Friday, ending a turbulent week that included a three-day sell-off in which some investors feared companies in the sector were overvalued (see BioCentury Extra, March …

    Published on 3/27/2015
  • FINANCIAL NEWS: PolyPid withdraws IPO

    PolyPid Ltd. (Petach Tikva, Israel) withdrew its proposed IPO on NASDAQ. CBO Asaf Bar said the company is confident it could have gone public under current market conditions, but anticipates undisclosed milestones in …

    Published on 3/27/2015
  • FINANCIAL NEWS: Cerenis raises EUR 53.4M in Euronext IPO

    Cardiovascular play Cerenis Therapeutics S.A. (Euronext:CEREN) raised EUR 53.4 million ($57.7 million) through the sale of 4.2 million shares at EUR 12.70 in an IPO on Euronext. The IPO price values Cerenis at EUR 225.9…

    Published on 3/26/2015
  • FINANCIAL NEWS: Flagship closes $537M Fund V

    Flagship Ventures closed its oversubscribed Flagship Ventures Fund V at $537 million, exceeding its original target of $300 million. Flagship plans to invest the fund in 25-30 companies, with up to 75% going to …

    Published on 3/26/2015
  • FINANCIAL NEWS: OSE Pharma raises EUR 21.1M in IPO

    OSE Pharma S.A. (Euronext:OSE) raised EUR 21.1 million ($22.8 million) in an IPO through the sale of 2 million shares at EUR 10.80. The price, which was the top of its proposed range of EUR 8-EUR 10.80, values the …

    Published on 3/26/2015
  • FINANCIAL NEWS: Cellectis raises $228.3M, lists in U.S.

    Immunotherapy company Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) lost $2.20 to $39.30 in its first day of trading on NASDAQ on Wednesday after raising $228.3 million through the sale of 5.5 million American Depositary…

    Published on 3/25/2015
  • FINANCIAL NEWS: ZS Pharma raises $185.7M in bumped-up follow-on

    ZS Pharma Inc. (NASDAQ:ZSPH) raised $185.7 million through the sale of 4 million shares at $46.25 in an bumped-up follow-on underwritten by JPMorgan; Credit Suisse; BMO Capital Markets; William Blair; and LifeSci …

    Published on 3/25/2015
  • FINANCIAL NEWS: Semma closes $44M series A round

    Semma Therapeutics Inc. (Cambridge, Mass.) raised $44 million in a series A round led by existing investor MPM Capital. Existing investor Fidelity Biosciences and new investors ARCH Venture Partners and Medtronic Inc. (…

    Published on 3/24/2015
  • FINANCIAL NEWS: Teva raises EUR 2B in debt offering

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) raised EUR 2 billion ($2.2 billion) in a senior notes offering to investors outside the U.S. The offering includes two components: EUR 1.3 billion ($1.4 billion) in notes …

    Published on 3/24/2015
  • FINANCIAL NEWS: Aeglea raises $44M in series B

    Aeglea BioTherapeutics Inc. (Austin, Texas) raised $44 million in a series B round led by existing investors Lilly Ventures and Novartis Venture Fund. Existing investor UT Horizon Fund and new investors OrbiMed; …

    Published on 3/23/2015
  • FINANCIAL NEWS: Malin raises EUR 302M for listed investment fund

    Malin Corp. plc (ISE:MLC) raised EUR 302 million ($318 million) in an IPO on the Irish Stock Exchange through the sale of 30.2 million shares at EUR 10. Earlier this year, former executives of Elan Corp. plc launched …

    Published on 3/20/2015
  • FINANCIAL NEWS: Nordic Nanovector raises NOK500M in IPO

    Hematology and oncology play Nordic Nanovector ASA (OSE:NANO) raised NOK500 million ($60.9 million) in an IPO through the sale of 15.6 million shares at NOK32, giving it a market cap of NOK1.3 billion ($164.4 million). …

    Published on 3/20/2015
  • FINANCIAL NEWS: Tekmira raises $151.9M in follow-on

    Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) raised $151.9 million through the sale of 7.5 million shares at $20.25 in a follow-on underwritten by Leerink; RBC Capital Markets; Nomura; JMP Securities; Wedbush PacGrow; …

    Published on 3/20/2015
  • FINANCIAL NEWS: Funding roundup: Esperion, Retrophin, Assembly, Concert

    Esperion Therapeutics Inc. (NASDAQ:ESPR), Retrophin Inc. (NASDAQ:RTRX), Assembly Biosciences Inc. (NASDAQ:ASMB) and Concert Pharmaceuticals Inc. (NASDAQ:CNCE) raised $430 million in follow-on offerings since market …

    Published on 3/19/2015
  • FINANCIAL NEWS: Epizyme raises $124.5M in follow-on

    Epizyme Inc. (NASDAQ:EPZM) raised $124.5 million through the sale of 6 million shares at $20.75 in a follow-on underwritten by Leerink; Cowen; RBC Capital Markets; JMP Securities; SunTrust Robinson Humphrey; and Mizuho …

    Published on 3/18/2015
  • FINANCIAL NEWS: Nimbus raises $43M series B round

    Nimbus Therapeutics LLC (Cambridge, Mass.) raised $43 million in a series B round led by Pfizer Venture Investments and Lightstone Ventures. Existing investors Atlas Venture, SR One, Lilly Ventures and Bill Gates also …

    Published on 3/18/2015
  • FINANCIAL NEWS: Vivo closes eighth fund with $750M

    Vivo Capital said it closed Vivo Capital Fund VIII with $750 million. Vivo intends to invest the fund in late-stage pharma and medical device companies in the U.S. and in revenue-stage healthcare companies in greater …

    Published on 3/18/2015
  • FINANCIAL NEWS: Funding roundup: Valeant, Eagle

    Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) and Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) raised $1.5 billion in follow-on offerings on Tuesday. Valeant raised $1.45 billion through the sale of 7.3 …

    Published on 3/17/2015
  • FINANCIAL NEWS: Industry backs U.K.'s $100M dementia fund

    The U.K. government unveiled its $100 million Dementia Discovery Fund to support dementia research. The fund's investors include GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Johnson & Johnson (NYSE:JNJ), Biogen Idec Inc.(…

    Published on 3/17/2015
  • FINANCIAL NEWS: Allergen raises $80M for peanut Phase III

    Allergen Research Corp. (San Mateo, Calif.) raised $80 million in a series B round led by Foresite Capital. Existing investor Longitude Capital and new investors Fidelity Management & Research Co.; Aisling Capital; …

    Published on 3/12/2015
  • FINANCIAL NEWS: AstraZeneca leads PhaseBio series C

    PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) raised $20 million in the first tranche of a planned $40 million series C round led by AstraZeneca plc (LSE:AZN; NYSE:AZN). Existing investors New Enterprise Associates, …

    Published on 3/12/2015
  • FINANCIAL NEWS: Funding round-up: Genocea, Depomed

    Infectious disease company Genocea Biosciences Inc. (NASDAQ:GNCA) raised $45 million through the sale of 5.5 million shares at $8.25 in a follow-on underwritten by Cowen; Piper Jaffray; Stifel; and Needham. Genocea …

    Published on 3/12/2015
  • FINANCIAL NEWS: Venture tracks

    Patrick Baeuerle will join MPM Capital as managing director on April 1. He most recently was VP of research and general manager at Amgen Research GmbH, and was CSO of Micromet Inc., which Amgen Inc. (NASDAQ:AMGN) …

    Published on 3/12/2015
  • FINANCIAL NEWS: Kythera raises $125M in follow-on

    Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) raised $125 million through the sale of 2.6 million shares at $48 in a follow-on underwritten by Goldman Sachs; BofA Merrill Lynch; Leerink; and Cowen. Kythera proposed the …

    Published on 3/11/2015
  • FINANCIAL NEWS: Tetraphase raises $150.5M in follow-on

    Infectious disease company Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) raised $150.5 million through the sale of 4.3 million shares at $35 in a follow-on underwritten by BMO Capital Markets; Stifel; Guggenheim …

    Published on 3/11/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993